ECTOPIC PREGNANCY;
MEDICAL MANAGEMENT
DOI:
https://doi.org/10.29309/TPMJ/2012.19.02.2021Keywords:
ß-hCG ,, Ectopic PregnancyAbstract
Objectives: To assess the effectiveness of systemic methotrexate for treatment of unruptured ectopic pregnancy. Introduction:
Ectopic Pregnancy is pregnancy that occurs in any location other than the uterus. 95% to 98% are tubal ectopics, but the number of ovarian,
abdominal and cervical implantations is rising as does the number of heterotopic pregnancies. Study Design: Prospective experimental study.
Setting: DHQ Hospital affiliated with Punjab Medical College Faisalabad. Period: Jan-2009 to Dec-2009. Patient & Method: A total of 45
women were admitted with diagnosis of extrauterine pregnancy. But only 10 women fulfilled the criteria for medical management. Out of these
80% patients required no surgical intervention. However 20% needed surgery. 60% patients suffered from lower abdominal or pelvic pain. 20%
required 2nd dose of methotrexate. Average ß-hCG resolution time was 35 days. Conclusions: With early diagnosis and proper selection
criteria adoption, medical treatment of ectopic pregnancy with systemic methotrexate is an effective and safe alternative to surgical
interventions.